Exhibit 4.6
SEASTAR MEDICAL, INC.
AMENDMENT TO WARRANT TO PURCHASE PREFERRED STOCK
THIS AMENDMENT TO THE WARRANT TO PURCHASE PREFERRED STOCK (this “Amendment”) is made and entered into as of [ ], 2022 by and between SeaStar Medical, Inc., a Delaware corporation (the “Company”) and the holder set forth on the signature page hereto (the “Holder”).
WHEREAS, the Company and the Holder are parties to [that][those] certain Warrant[s] to Purchase Preferred Stock set forth in Exhibit A attached hereto (each a “Warrant”). All capitalized terms used in this Amendment but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Warrant;
WHEREAS, in connection with the SPAC Merger (as defined below), the parties hereto desire to amend each Warrant in accordance with the terms set forth herein; and
WHEREAS, Section 10 of the Warrant requires the written consent of the Company and Holders of at least sixty-six and two-thirds (66 2/3%) of the outstanding Warrants to amend or waive any terms of such Warrant, provided that all Warrants are similarly amended or waived.
NOW, THEREFORE, in consideration of the foregoing and the promises and covenants contained herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the undersigned hereby agree as follows:
1. A new Section 5.4 shall be added to each Warrant as follows:
SPAC Merger Conversion. The Company entered into an Agreement and Plan of Merger, as amended (the “Merger Agreement”), by and among the Company, LMF Acquisition Opportunities, Inc., a Delaware corporation (the “Acquiror”), LMF Merger Sub, Inc., a Delaware corporation and direct, wholly owned subsidiary of Acquiror (“Merger Sub”) pursuant to which Merger Sub shall merge with and into the Company (the “SPAC Merger”), with the Company as the surviving corporation, and Acquiror changing its name to “SeaStar Medical Holding Corporation” and all outstanding shares of capital stock of the Company will be exchanged into shares of common stock of Acquiror (the “SPAC Common Stock”) pursuant to the exchange ratio and other terms of the Merger Agreement.
Therefore, notwithstanding anything to the contrary herein, effective upon and subject to the consummation of the SPAC Merger:
(a) this Warrant shall become exercisable for such whole number of shares of SPAC Common Stock (rounded down to the nearest whole share) equal to the product of (A) the number of Exercise Shares (as calculated on an as converted to Exercise Shares basis) subject to this Warrant immediately prior to the closing of the SPAC Merger multiplied by (B) the Exchange Ratio (as defined in the Merger Agreement) for such Exercise Shares;